Abbott Labs' Humira honored
Merck & Co.'s Remicade, Pfizer Inc.'s Enbrel and Libertyville Township-based Abbott Laboratories' Humira won the backing of the U.K. National Institute for Health and Clinical Excellence for use in patients with "active and progressive" psoriatic arthritis.
The drugs are recommended for patients who haven't responded to previous treatment, the agency said today in an e- mailed statement.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.